Trends in missed presentations and late HIV diagnosis in a UK teaching hospital: a retrospective comparative cohort study

Jared Wohlgemut, Timothy Lawes, Robert B S Laing, Jared Wohlgemut, Timothy Lawes, Robert B S Laing

Abstract

Background: Late diagnosis is an important cause of HIV-related morbidity, mortality and healthcare costs in the UK and undiagnosed infection limits efforts to reduce transmission. National guidelines provide recommendations to increase HIV testing in all healthcare settings. We evaluated progress towards these recommendations by comparing missed opportunities for HIV testing and late diagnosis in two six year cohorts from North East Scotland.

Methods: We reviewed diagnostic pathways of all patients newly diagnosed with HIV referred to infectious diseases and genito-urinary medicine services between 1995 and 2000 (n=48) and 2004 to 2009 (n=117). Missed presentations (failure to diagnose≤1 month of a clinical or non-clinical indicator for testing), late diagnosis (CD4<350 cells/mm3), and time to diagnosis (months from first presentation to diagnosis) were compared between cohorts using χ2 and log-rank tests. Determinants of missed presentation were explored by multivariate logistic regression. Breslow-Day tests assessed change in diagnostic performance by patient subgroup.

Results: There were significant decreases in missed presentations (33% to 17%; P=0.02) and time to diagnosis (mean 17 months to 4 months; P=0.005) but not in late diagnosis (56% vs. 60%; P=0.57) between earlier and later cohorts. In the later cohort patients were significantly more likely to have acquired HIV abroad and presented with early HIV disease, and testing was more likely to be indicated by transmission risk or contact with GUM services than by clinical presentation. Missed presentation remained significantly less likely in the later cohort (OR=0.28, 95% CI 0.11 to 0.72; P=0.008) after adjustment for age, transmission risks and number of clinical indicators. Reductions in missed presentation were greater in patients<40 years, of non-UK origin, living in least deprived neighbourhoods and with early disease at presentation (P<0.05). 27% of missed presentations occurred in primary care and 46% in general secondary care.

Conclusions: While early diagnosis has improved in epidemiological risk groups, clinical indications for HIV testing continue to be missed, particularly in patients who are older, of UK origin and from more deprived communities. Increasing testing in non-specialist services is a priority.

Figures

Figure 1
Figure 1
Missed and diagnosed clinical presentations as percentage of total cohort.
Figure 2
Figure 2
Risk of missed presentation by time period stratified by clinical and epidemiological risk factors. * Breslow-Day test of homogeneity of variance: P < 0.05 suggesting significant heterogeneity within the strata. † Not calculable due to small numbers. Transmission risks of IVDU, partner HIV positive, recipients of blood products/organs or dialysis patients were not calculated due to small numbers.
Figure 3
Figure 3
Kaplan-Meier curves of time to diagnosis from first presentation by cohort. (Log-rank test, P = 0.005).

References

    1. UNAIDS/WHO. Guidance on Provider-Initiated HIV testing and counselling in health facilities. Geneva: World Health Organisation and Joint United Nations Programme on HIV/AIDS; 2006.
    1. Centers for Disease Control and Prevention. HIV prevalence estimates--United States, 2006. Morb Mortal Wkly Rep. 2008;57(39):1073–1076.
    1. European Center for the Epidemiological Monitoring of AIDS. End-Year Report 2006. EuroHIV. 2007.
    1. De Cock KM, Johnson AM. From exceptionalism to normalisation: a reappraisal of attitudes and practice around HIV testing. BMJ. 1998;316(7127):290–293. doi: 10.1136/bmj.316.7127.290.
    1. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20:1447–1450. doi: 10.1097/01.aids.0000233579.79714.8d.
    1. Sabin CA, Smith CJ, Gumley H, Murphy G, Lampe FC, Phillips AN, Prinz B, Youle M, Johnson MA. Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS. 2004;18(16):2145–2151. doi: 10.1097/00002030-200411050-00006.
    1. Lucas SB, Curtis H, Johnson MA. National review of deaths among HIV-infected adults. Clin Med. 2008;8(3):250–252.
    1. Fleishman JA, Yehia BR, Moore RD, Gebo KA. The economic burden of late entry into medical care for patients with HIV infection. Med Care. 2010;48(12):1071–1079. doi: 10.1097/MLR.0b013e3181f81c4a.
    1. Sir Liam Donaldson, CMO & Christine Beasley, CNO. Improving the detection and diagnosis of HIV in non- HIV specialties including primary care.
    1. British HIV Association, British Association of Sexual Health and HIV, British Infection Society. UK National Guidelines for HIV Testing 2008. London: BHIVA/BASHH/BIS; 2008.
    1. Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, Rydzak CE, Douglass LR, Lazzeroni LC, Holodniy M, Owens DK. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. New Engl J Med. 2005;352:570–585. doi: 10.1056/NEJMsa042657.
    1. Sullivan AK, Curtis H, Sabin CA, Johnson MA. Newly diagnosed HIV infections: review in UK and Ireland. BMJ. 2005;330(7503):1301–1302. doi: 10.1136/bmj.38398.590602.E0.
    1. Ratcliffe L, Thomas S, Beeching NJ, Phillips-Howard PA, Taegtmeyer M. Acute presentations of HIV are still missed in low prevalence areas. Postgrad Med J. 2011;87(1025):170–174. doi: 10.1136/pgmj.2010.109801.
    1. McDaid LM, Hart GJ. Increased HIV testing and reduced undiagnosed infection among gay men in Scotland, 2005-8: support for the opt-out testing policy? Sex Transm Infect. 2011;87(3):221–224. doi: 10.1136/sti.2010.044560.
    1. World Health Organisation. Interim WHO clinical staging of HIV/AIDS and HIV/AIDS case definitions for surveillance. Geneva. 2005.
    1. Scottish Neighbourhood Statistics. The Scottish Government.
    1. Spencer N, Bambang S, Logan S, Gill L. Socioeconomic status and birth weight: comparison of an area based measure with the registrar general's social class. J Epidemiol Community Health. 1999;53:495–498. doi: 10.1136/jech.53.8.495.
    1. Smith GD, Hart C, Watt G, Hole D, Hawthorne V. Individual social class, area-based deprivation, cardiovascular disease risk factors, and mortality: the Renfrew and Paisley Study. J Epidemiol Community Health. 1998;52:399–405. doi: 10.1136/jech.52.6.399.
    1. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Adopted 1964, Amended 1975, 1983, 1989, 1996, 2000, 2002, 2004 and 2008: [ ]
    1. Mackenzie AR, Laing RB, Urbaniak SJ, Molyneaux PJ, Douglas JG, Smith CC. Epidemiology and outcome of HIV infection in North-East Scotland (1985-1997) J Infect. 1999;38(2):107–110. doi: 10.1016/S0163-4453(99)90077-4.
    1. Mabey D, Mayaud P. Sexually transmitted diseases in mobile populations. Genitourin Med. 1997;73:18–22.
    1. Burns FM, Johnson AM, Nazroo J, Ainsworth J, Anderson J, Fakoya A, Fakoya I, Hughes A, Jungmann E, Sadiq ST, Sullivan AK, Fenton KA. SONHIA Collaboration Group. Missed opportunities for earlier HIV diagnosis within primary and secondary healthcare settings in the UK. AIDS. 2008;22(1):115–122. doi: 10.1097/QAD.0b013e3282f1d4b6.
    1. Delpierre C, Dray-Spira R, Cuzin L, Marchou B, Massip P, Lang T, Lert F. VESPA Study Group. Correlates of late HIV diagnosis: implications for testing policy. Int J STD AIDS. 2007;18(5):312–317. doi: 10.1258/095646207780749709.
    1. Health Protection Agency Centre for Infections, Health Protection Scotland, UCL Institute of Child Health. United Kingdom New HIV Diagnoses to end of December 2010. London; Health Protection Agency; 2011.
    1. Kaufmann GR, Bloch M, Finlayson R, Zaunders J, Smith D, Cooper DA. The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy. AIDS. 2002;16(3):359–367. doi: 10.1097/00002030-200202150-00007.
    1. Zenilman JM, Shahmanesh M, Winter AJ. Ethnicity and STIs: more than black and white. Sex Transm Infect. 2001;77(1):2–3. doi: 10.1136/sti.77.1.2.
    1. Srinivasan R, Menon L, Stevens P, Campbell I, Alfaham M. Ethnic differences in selective neonatal BCG immunisation: white British children miss out. Thorax. 2006;61(3):247–249. doi: 10.1136/thx.2004.036269.
    1. Gossop M, Powis B, Griffiths P, Strang J. Multiple risks for HIV and hepatitis B infection among heroin users. Drug Alcohol Rev. 1994;13:293–300. doi: 10.1080/09595239400185391.
    1. Rodrigo T, Cayla JA, de Garcia Olalla P, Galdos-Tanguis H, Jansa JM, Miranda P, Brugal T. Characteristics of tuberculosis patients who generate secondary cases. Int J Tuberc Lung Dis. 1997;1(4):352–357.
    1. Scaradavou A. HIV-related thrombocytopenia. Blood Rev. 2002;16(1):73–76. doi: 10.1054/blre.2001.0188.
    1. Fox J, Nastouli E, Thomson E, Muir D, McClure M, Weber J, Fidler S. Increasing incidence of acute hepatitis C in individuals diagnosed with primary HIV in the United Kingdom. AIDS. 2008;22(5):666–668. doi: 10.1097/QAD.0b013e3282f5f4cf.
    1. Hung CC, Hsiao CF, Wang JL, Chen MY, Hsieh SM, Sheng WH, Chang SC. Herpes zoster in HIV-1-infected patients in the era of highly active antiretroviral therapy: a prospective observational study. Int J STD AIDS. 2005;16(10):673–676. doi: 10.1258/095646205774357271.
    1. Johnson NW. The mouth in HIV/AIDS: markers of disease status and management challenges for the dental profession. Aust Dent J. 2010;55(Suppl 1):85–102.
    1. Sudarshi D, Pao D, Murphy G, Parry J, Dean G, Fisher M. Missed opportunities for diagnosing primary HIV infection. Sex Transm Infect. 2008;84(1):14–16. doi: 10.1136/sti.2007.026963.
    1. Lee V, Foley E, Patel R. Evaluation of time for non-GU medicine physicians to diagnose HIV infection in patients presenting with HIV-related illnesses. Int J ST AIDS. 2006;17:97–98. doi: 10.1258/095646206775455739.
    1. Aicken CR, Cassell JA, Estcourt CS, Keane F, Brook G, Rait G, White PJ, Mercer CH. Rationale and development of a survey tool for describing and auditing the composition of, and flows between, specialist and community clinical services for sexually transmitted infections. BMC Health Serv Res. 2011;11:30. doi: 10.1186/1472-6963-11-30.
    1. Castilla J, Sobrino P, De La Fuente L, Noguer I, Guerra L, Parras F. Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. AIDS. 2002;16(14):1945–1951. doi: 10.1097/00002030-200209270-00012.
    1. Hamill M, Burgoine K, Farrell F, Hemelaar J, Patel G, Welchew DE, Jaffe HW. Time to move towards opt out testing for HIV in the UK. BMJ. 2007;334(7608):1352–1354. doi: 10.1136/bmj.39218.404201.94.
    1. Peck L, Ferenczi E, Burns F, Cosgrove C, Brown M. Barriers to targeted HIV testing on an acute admissions unit: evaluation of the UK guideline. QJM. 2010;103(3):147–151. doi: 10.1093/qjmed/hcp185.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever